STAT+: Humanigen says it drug keeps Covid patients off ventilators. But are some data missing?
A small biotech firm, Humanigen, said Monday that its experimental drug reduced the risk of patients hospitalized with Covid-19 being put on ventilators.
Shares in the company rose 86% on the news, and Humanigen said it would ask the Food and Drug Administration to grant an emergency use authorization based on the results.
